Compare Kodiak Gas Services Inc. Common Stock (KGS) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kodiak Gas Services Inc. Common Stock vs Organon & Co. Common Stock — how do they compare? Kodiak Gas Services Inc. Common Stock trades at $50.49 (market cap $5.26B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Kodiak Gas Services Inc. Common Stock is the larger of the two by market cap, and Kodiak Gas Services Inc. Common Stock pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold Kodiak Gas Services Inc. Common Stock for 6 Days and Organon & Co. Common Stock for 0 Days on average.
| KGS | OGN | |
|---|---|---|
Market Cap | $5.26B | $3.62B |
Volume | 2,807,958 | 2,892,999 |
Sector | Energy | Health |
52-Week High | $76.27 | $13.81 |
52-Week Low | $32.95 | $5.70 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $7.94B | $11.04B |
Dividend Yield | 3.77% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KGS trades at $52.00, down 0.93% on the day, with technical indicators showing a bearish trend. The company reported Q2 2026 revenue growth but missed earnings expectations for three consecutive quarters. Recent developments include a significant power supply agreement for West Texas data centers, positioning KGS for future growth in distributed power generation.
Despite recent earnings misses, analyst consensus remains strongly bullish with a $80.38 price target representing 55% upside potential. Key risks include execution challenges in expanding power capacity and continued earnings volatility. The company's strategic pivot toward data center power services offers substantial growth opportunity if successfully executed.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kodiak Gas Services Inc. Common Stock
Kodiak Gas Services, Inc. is a Texas-based provider of large-horsepower contract natural gas compression services, operating a fleet of roughly 4.5 million revenue-generating horsepower for oil and gas producers and midstream companies across major US production basins, including the Permian, Eagle Ford, and DJ Basin.
Read more on KGS →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
